![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Thursday, June 24, 2021 7:44:42 PM
Drug containing the active ingredient Aviptadil for inhalation/topical therapy.
Aviptadil (Vasoactive intestinal peptide (VIP)) is a peptide in the body that is already approved for another indication (ectile dysfunction) with an excellent safety profile.
The preclinic for inhalation therapy is available. Studies and casuistics show excellent efficacy and compatibility of the drug
Patients with sarcoidosis and related diseases (e.g. Berylliosis), have already benefited significantly from off-label treatment, so that many health insurance companies bear the treatment costs.
The simple application is done with a nebulizer of the latest generation.
In addition to product development for human medicine, products for veterinary medicine (especially for horses) are also to be developed.
https://advita-lifescience.com/wirkstoffe/
~ Money Making Money ~
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM